收藏切换
Research progress on the regulation of NLRP3 inflammasome activity by traditional Chinese medicine for the treatment of gouty arthritis
收藏切换
Dong-yi CAO1, Xiao-lin YUAN1, Hang-yi PU2, Yan-fen NIU3, Zheng-yan LI1, *
Acta Pharmaceutica Sinica | 2026, 61(6) : 2008 - 2019
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(6): 2008-2019
• Reviews •
Research progress on the regulation of NLRP3 inflammasome activity by traditional Chinese medicine for the treatment of gouty arthritis
Full
Dong-yi CAO1, Xiao-lin YUAN1, Hang-yi PU2, Yan-fen NIU3, Zheng-yan LI1, *
Affiliations
  • 1Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming 650500, China
  • 2Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China
  • 3Kunming Medical University, Kunming 650500, China
Published: 2026-06-12 doi: 10.16438/j.0513-4870.2025-1449
Outline
收藏切换

Gouty arthritis is an inflammatory joint disease triggered by urate crystal deposition, with nucleotide binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome overactivation serving as the core driver of its acute inflammatory response. Although NLRP3-targeting drugs have advanced to clinical trials, their clinical application remains limited by adverse effects and uncertain long-term risks. In this context, traditional Chinese medicine (TCM), with its multi-component, multi-target, and synergistic regulatory properties, offers novel strategies for the prevention and treatment of gout. Studies have shown that TCM exerts multidimensional therapeutic effects, including alleviation of acute joint inflammation, reduction of serum uric acid levels, and prevention of disease recurrence, underscoring its potential for systemic intervention. This review systematically summarizes the mechanisms by which active components and formulations of TCM modulate key aspects of NLRP3 inflammasome activation pathways. These include inhibition of upstream initiation signals, blockade of activation signal transduction, direct interference with inflammasome assembly, and enhancement of autophagic clearance, collectively leading to suppressed release of key inflammatory mediators such as IL-1β. This review aims to provide theoretical foundations and directional insights for further research and clinical application of TCM regulating NLRP3 in gouty arthritis treatment.

gouty arthritis  /  NLRP3 inflammasome  /  traditional Chinese medicine  /  active component  /  signaling pathway
曹东怡, 袁小淋, 普行艺, 牛艳芬, 李争艳. 中药调控NLRP3炎症小体活性治疗痛风性关节炎的研究进展. 药学学报, 2026 , 61 (6) : 2008 -2019 . DOI: 10.16438/j.0513-4870.2025-1449
Dong-yi CAO, Xiao-lin YUAN, Hang-yi PU, Yan-fen NIU, Zheng-yan LI. Research progress on the regulation of NLRP3 inflammasome activity by traditional Chinese medicine for the treatment of gouty arthritis[J]. Acta Pharmaceutica Sinica, 2026 , 61 (6) : 2008 -2019 . DOI: 10.16438/j.0513-4870.2025-1449
Year 2026 volume 61 Issue 6
324
150
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-1449
  • Receive Date:2025-12-03
  • Online Date:2026-09-21
  • Published:2026-06-12
Article Data
Affiliations
History
  • Received:2025-12-03
  • Revised:2026-02-02
Affiliations
    1Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming 650500, China
    2Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China
    3Kunming Medical University, Kunming 650500, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-1449
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT